Natco Pharma Limited has informed the Exchange about Schedule of meet
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has scheduled an investor and analyst call on 23rd July 2025 at 5:00 p.m. IST. The call will focus on discussing a proposed investment by the company. Details of the proposed investment, such as the size, sector, or target, have not been disclosed in this filing. Investors and analysts can join the call through a link shared in the announcement. The disclosure was signed by Ch. Venkat Ramesh, Company Secretary and Compliance Officer.
This is a forward-looking signal that Natco Pharma may be planning a new investment, acquisition, or capital expenditure. The actual impact on the stock will depend on what the company reveals during the call, so investors should wait for the details before drawing conclusions.